Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Assets
Cash and cash equivalents	$ 409,039	$ 1,276,654
Inventory	4,131
Prepaid expense and other current assets	32,124	26,580
Total current assets	445,294	1,303,234
Patents, net	146,263	146,456
Property and equipment, net	5,069	14,010
Total assets	596,626	1,463,700
Liabilities and Stockholders’ Equity (Deficit)
Accounts payable and accrued expenses	208,727	115,313
Advances from investors	100,000	104,952
Convertible notes payable	444,581	513,356
Total current liabilities	753,308	733,621
Total liabilities	753,308	733,621
Commitments and contingencies
Stockholders’ equity (deficit)
Preferred stock, $0.01 par value: Authorized shares – 10,000,000, Issued and outstanding shares – 0 at December 31, 2019 and December 31, 2018, respectively
Common stock, $0.01 par value: Authorized shares – 100,000,000, Issued and outstanding shares –40,516,351 and 39,117,524 at December 31, 2019 and 2018, respectively	405,164	391,175
Additional paid-in capital	4,207,786	3,527,238
Accumulated deficit	(4,769,632)	(3,188,334)
Total stockholders’ equity (deficit)	(156,682)	730,079
Total liabilities and stockholders’ equity (deficit)	$ 596,626	$ 1,463,700